GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Frontage Holdings Corp (HKSE:01521) » Definitions » 3-Year ROIIC %

Frontage Holdings (HKSE:01521) 3-Year ROIIC % : -9.25% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Frontage Holdings 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Frontage Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2024 was -9.25%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Frontage Holdings's 3-Year ROIIC % or its related term are showing as below:

HKSE:01521's 3-Year ROIIC % is ranked better than
52.78% of 1387 companies
in the Biotechnology industry
Industry Median: -15.47 vs HKSE:01521: -9.25

Frontage Holdings 3-Year ROIIC % Historical Data

The historical data trend for Frontage Holdings's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frontage Holdings 3-Year ROIIC % Chart

Frontage Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only 3.17 4.59 3.66 -0.23 -9.25

Frontage Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.66 - -0.23 - -9.25

Competitive Comparison of Frontage Holdings's 3-Year ROIIC %

For the Biotechnology subindustry, Frontage Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Frontage Holdings's 3-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Frontage Holdings's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Frontage Holdings's 3-Year ROIIC % falls into.


;
;

Frontage Holdings 3-Year ROIIC % Calculation

Frontage Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2024 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 16.3758528 (Dec. 2024) - 167.8278582 (Dec. 2021) )/( 3943.624 (Dec. 2024) - 2306.195 (Dec. 2021) )
=-151.4520054/1637.429
=-9.25%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Frontage Holdings  (HKSE:01521) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Frontage Holdings 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Frontage Holdings's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Frontage Holdings Business Description

Traded in Other Exchanges
N/A
Address
700 Pennsylvania Drive, Exton, PA, USA, 19341
Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical, and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include drug discovery, drug development, pharmaceutical product development, and laboratory testing in the USA and Canada; and the PRC segment includes the same services provided in the People's Republic of China. The company generates a majority of its revenue from USA followed by the PRC and the rest of the world.
Executives
Hongkong Tigermed Co., Limited
Hang Zhou Tai Ge Yi Yao Ke Ji Gu Fen You Xian Gong Si 2101 Beneficial owner
Li Song 2101 Beneficial owner
Kabouter Management Llc 2102 Investment manager
Hangzhou Tigermed Consulting Co., Ltd.

Frontage Holdings Headlines

No Headlines